Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | LGALS8 | O00214 | 4/20 | 0.46 |
| ▸ | LGALS3 | P17931 | 3/20 | 0.46 |
| ▸ | LGALS4 | P56470 | 2/20 | 0.46 |
| ▸ | IGF2R | P11717 | 1/20 | 0.45 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.44 |
| ▸ | LGALS9 | O00182 | 1/20 | 0.43 |
| ▸ | LGALS1 | P09382 | 1/20 | 0.43 |
| ▸ | LGALS7; LGALS7B | P47929 | 1/20 | 0.43 |
| ▸ | GJA1 | P17302 | 1/20 | 0.43 |
| ▸ | GJB2 | P29033 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | SLC28A3 | Q9HAS3 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | FGF1 | P05230 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5544380 | 0.88 | LGALS3 (0.53) | MEN1KMT2ALGALS8LGALS3LGALS4 | |
| SCHEMBL5086308 | 0.88 | LGALS3 (0.53) | MEN1KMT2ALGALS8LGALS3LGALS4 | |
| SCHEMBL1984503 | 0.87 | LGALS8 (0.52) | MEN1KMT2ALGALS8LGALS3LGALS4 | |
| SCHEMBL6060841 | 0.86 | SLC28A3 (0.50) | LGALS8SLC28A3 | |
| SCHEMBL2429112 | 0.86 | SLC28A3 (0.50) | LGALS8SLC28A3 | |
| SCHEMBL8361874 | 0.86 | SLC28A3 (0.50) | LGALS8SLC28A3 | |
| SCHEMBL3144958 | 0.86 | SLC28A3 (0.50) | LGALS8SLC28A3 | |
| SCHEMBL22047951 | 0.86 | SLC28A3 (0.50) | LGALS8SLC28A3 | |
| SCHEMBL22026379 | 0.86 | SLC28A3 (0.50) | LGALS8SLC28A3 | |
| SCHEMBL5199795 | 0.86 | SLC28A3 (0.50) | LGALS8SLC28A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210147463-A1 | Methods for Purifying Steviol Glycosides and Uses of the Same | PURECIRCLE SDN BHD (MY) | 2021-05-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210147463-A1 | Methods for Purifying Steviol Glycosides and Uses of the Same | RDX, TAS2R7, SORD | MEN1 3715/4885KMT2A 2399/4885LGALS8 2039/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.